Artificial intelligence (AI) has transitioned from a promising concept to an indispensable pillar of modern ophthalmic care. Few specialties have embraced technology as rapidly and effectively as ophthalmology, where imaging-rich workflows, structured data, and high disease burden have created an ideal environment for AI innovation. As we move into an era where AI is no longer merely an assistive tool but a collaborative partner, the scope of its influence is expanding well beyond screening. From Automation to Acceleration in Screening AI’s earliest clinical successes emerged in diabetic retinopathy screening, where FDA-cleared autonomous systems demonstrated the ability to triage patients efficiently and accurately. Similar gains are now being observed in glaucoma suspects, ROP screening, keratoconus detection, and even community-level cataract grading. The true impact, however, lies not only in sensitivity or specificity but in democratizing access. AI-driven screening networks allow eye care to reach underserved populations, reduce referral burdens, and optimize chair time for specialists. Decision Support in Daily Practice AI-algorithms have now embedded themselves within everyday diagnostics—OCT interpretation, visual field progression analysis, and keratometric classification. Devices powered by machine learning flag subtle changes long before they become clinically apparent, supporting clinicians in navigating large datasets with greater consistency and speed. Importantly, AI is reshaping practice patterns by reducing diagnostic variability and promoting data-driven decision-making. The Next Leap: Predictive Analytics The frontier of AI in ophthalmology is shifting from detecting disease to predicting it. Predictive analytics—built on multimodal data from imaging, genetics, systemic disease profiles, and longitudinal records—offers unprecedented opportunities: Predicting glaucoma progression and personalized target IOP. Forecasting post-operative refractive outcomes in cataract and refractive surgery using AI-enhanced biometry. Estimating risk of keratoconus progression to tailor cross-linking timing. Defining treatment intervals in retinal diseases, reducing the trial-and-error burden of anti-VEGF therapy. These advances support precision ophthalmology, where each decision aligns more closely with an individual patient’s risk profile. Addressing the Barriers: Ethics, Bias, and Implementation Despite promise, real-world adoption is not without challenges. Algorithmic bias remains a concern when training datasets fail to represent diverse populations. The medicolegal status of autonomous systems, data privacy regulations, and the need for clear clinical governance pathways require thoughtful navigation. Equally essential is clinician trust. AI should enhance, not replace, clinical judgment. Ophthalmologists must remain at the center of this transformation—interpreting, validating, and contextualizing AI output within the patient’s broader health framework. A Vision for the Future AI-augmented ophthalmology is shifting from reactive care to proactive, personalized eye health. As predictive analytics matures, clinicians will be equipped with foresight that reshapes how we prevent blindness, allocate resources, and design treatment pathways. The goal is not to replace the ophthalmologist but to elevate the ophthalmologist’s capabilities—enabling earlier intervention, more precise treatments, and better patient outcomes. The coming decade will define how effectively we integrate these tools into practice. What remains clear is that the partnership between human expertise and machine intelligence is no longer speculative—it is the new standard of care. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
Mahipal S. Sachdev (2024) studied this question.